Form 4 for WGS GeneDx Holdings Corp.
Accepted 2025-09-18 00:00:00 ET · period of report 2025-09-16 · accession 0001689575-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-18 | 2025-09-16 | WGS | Stueland Katherine | CEO, Dir | S - Sale+OE | $121.47 | -10.5K | 14.6K | -42% | -$1.28M |
| D | 2025-09-18 | 2025-09-16 | WGS | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +18.8K | 25.1K | +296% | $0 |
| D | 2025-09-18 | 2025-09-16 | WGS | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | -18.8K | 112.5K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-09-16 | S | D | 10,501 | $121.47 | 14,578 | D | — | — | (F3) The price reported is a weighted average price. These shares were sold as part of a block trade for multiple security holders of the Issuer in multiple transactions at prices ranging from $118.28 to $123.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3 with regard to the block trade. (F4) Following the reported sales, in addition to the 14,578 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 444,539 shares of Class A common stock and options to purchase up to an aggregate of 107,610 shares of Class A common stock, which RSUs and options vest according to their respective terms. |
| 2 | Common | Class A Common Stock | 2025-09-16 | M | A | 18,750 | $0.00 | 25,079 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. |
| 3 | Derivative | Restricted Stock Unit | 2025-09-16 | M | D | 18,750 | $0.00 | 112,500 | D | — · — to — | 18,750 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F5) 6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. |